🇺🇸 FDA

Intelligence · Patent portfolio

Axsome Therapeutics Patents

Full USPTO pharma patent portfolio for Axsome Therapeutics — grant dates, expiration, and drug cross-links.

Patents
162
Expiring ≤24m
0

Quick answer

Axsome Therapeutics has 162 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 4

  1. US 11771666

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11771667

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11759522

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11738085

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11712441

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11713292

    Treatment of cataplexy

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11660274

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11648232

    Methods and compositions for treating excessive sleepiness

    Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11628173

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11617791

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11617756

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11617755

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11607456

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11602563

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11571428

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11560354

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11510927

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11504429

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11497725

    Treatment for obesity

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11471464

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11471465

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11439597

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11433079

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11433035

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11433078

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11426414

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11369684

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11364245

    Use of reboxetine to treat narcolepsy

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11357854

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11351175

    Use of reboxetine to treat narcolepsy

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11344514

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11344513

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11331323

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11331285

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11291639

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11285215

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11285214

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11285213

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11266657

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11219626

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11207328

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11207327

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11185550

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11185547

    Use of reboxetine to treat narcolepsy

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11179352

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11179351

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11135295

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11135226

    Use of reboxetine to treat narcolepsy

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

162 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.